MÆDICA - a Journal of Clinical Medicine Logo
  • Home
  • Profile
  • Standards
    • Types of articles
    • Instructions for authors
    • Editing rules (peer-review protocol)
    • Official Journal’s protocols
  • Peer-review TEAM
  • Editorial Council
  • How to
  • Menu

Author archives

  • About
  • Latest Posts

Anca Andreea ANDRONIC

Latest posts by Anca Andreea ANDRONIC (see all)

  • Heart Failure with Mid-Range Ejection Fraction – a New Category of Heart Failure or Still a Gray Zone - January 17, 2017

Articles signed on MÆDICA, JCM:

Heart Failure with Mid-Range Ejection Fraction – a New Category of Heart Failure or Still a Gray Zone

SELECT ISSUE

MÆDICA - a Journal of Clinical Medicine | Vol. 11, nr. 4, 2016
ISSN 1841-9038  |  e-ISSN 2069-6116
ISSN-L 1841-9038
CNCSIS - CMR - B+

HIGHLIGHTS

Plagiatul – in actualitate

Tema plagiatului este tot mai mult discutata in ultima vreme. Aparitia unor programe performante de cautare si identificare a similitudinilor intre texte [...]

Committe on Publication Ethics

A forum for responsible and ethical research publishing – Code of Conduct and Best Practice Guidelines for Journal Editors.

Members Area


Heart Failure with Mid-Range Ejection Fraction – a New Category of Heart Failure or Still a Gray Zone

Anca Andreea ANDRONIC, Sorina MIHAILA and Mircea CINTEZA

ABSTRACT

Heart failure with midrange ejection fraction (HFmrEF) is a new category of heart failure (HF), inbetween HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF).
Previous studies were mainly conducted in HFrEF patients having a left ventricle ejection fraction (LVEF) lower than 35-40%. Later on, HFpEF captured the spot-light of the research field, and studies focused on patients with HF symptoms, but with a LVEF exceeding 50%.
Consequently, a gap of knowledge comprising the LVEF between 40 and 49% has arisen. Current studies focusing on patients with HFmrEF are arguing the same conclusions or even having contradictory findings.
HFmrEF has a prevalence of 10-20% of HF patients. HFmrEF has distinct, but intermediate clinical, structural and functional characteristics, as well as intermediate outcomes in comparison with HFrEF and HFpEF. However, there is still a large gap in evidence regarding detailed hemodynamic characteristics, long-term follow-up and optimal therapeutic options for these patients.
Extensive research was recommended in order to improve knowledge about this “gray area” of patients with HF. Therefore, we aimed to provide an over-view of the existing and lacking data regarding patients
with HFmrEF.
Keywords: Heart failure, mid range ejection fraction

Full text | PDF



SEARCH

STANDARDS

  • Types of articles
  • Instructions for authors
  • Peer-review protocol
  • Official Journal’s protocols

Submit article

You can submit your article to the editors by using the form here:

SUBMIT

Partners

CONFERINTA NATIONALA ALZHEIMER 2018
SIMPOZIONUL DE VENTILATIE MECANICA 2018

plic-mailinfo@maedica.ro

 Terms and conditions

© MÆDICA - a Journal of Clinical Medicine - All rights reserved